Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,47 USD | +6,52% | -5,16% | -85,02% |
23/04 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. : JPMorgan Chase abbassa il rating a Neutral | ZM |
18/04 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. : giudizio positivo da Scotiabank | ZM |
Attività
Numero di dipendenti: 796
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Instrument
60,1
%
| 49 | 38,0 % | 120 | 60,1 % | +147,24% |
Consumable
31,6
%
| 60 | 46,7 % | 63 | 31,6 % | +5,74% |
Service and Other
8,3
%
| 20 | 15,3 % | 17 | 8,3 % | -15,08% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Americas
52,6
%
| 70 | 54,2 % | 105 | 52,6 % | +51,54% |
Asia-Pacific
27,2
%
| 36 | 28,2 % | 54 | 27,2 % | +50,65% |
Europe, Middle East, and Africa
20,3
%
| 23 | 17,6 % | 41 | 20,3 % | +79,92% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 14/07/00 |
Christian Henry
CEO | Chief Executive Officer | 56 | 01/08/18 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 28/09/20 |
Mark van Oene
COO | Chief Operating Officer | 51 | 08/01/21 |
Jonas Korlach
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/04 |
Kathy Ordoñez
BRD | Director/Board Member | 73 | 17/12/14 |
Todd Friedman
IRC | Investor Relations Contact | - | - |
Mike Goloubef
PRN | Corporate Officer/Principal | - | 01/01/20 |
Natalie Welch
HRO | Human Resources Officer | - | 01/10/08 |
Neil Ward
PRN | Corporate Officer/Principal | - | 08/06/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 18/07/13 |
Marshall Mohr
BRD | Director/Board Member | 67 | 18/01/12 |
Christian Henry
CEO | Chief Executive Officer | 56 | 01/08/18 |
Director/Board Member | 70 | 01/01/09 | |
Lucy Shapiro
BRD | Director/Board Member | 83 | 12/09/12 |
Bill Ericson
BRD | Director/Board Member | 65 | 01/01/04 |
Kathy Ordoñez
BRD | Director/Board Member | 73 | 17/12/14 |
David Meline
BRD | Director/Board Member | 66 | 13/10/23 |
Hannah Valantine
BRD | Director/Board Member | 72 | 16/06/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 267 951 880 | 260 406 548 ( 97,18 %) | 0 | 97,18 % |
Coordinate società
Pacific Biosciences of California, Inc.
1305 O'Brien Drive
94025, Menlo Park
+650 521 8000
http://www.pacb.comSettore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-85,02% | 400 Mln | |
+8,07% | 219 Mrd | |
+6,59% | 183 Mrd | |
+11,26% | 133 Mrd | |
+26,57% | 108 Mrd | |
+13,35% | 52,02 Mrd | |
-0,62% | 48,2 Mrd | |
-0,93% | 40,37 Mrd | |
+11,54% | 39,35 Mrd | |
+26,76% | 32,03 Mrd |
- Borsa valori
- Azioni
- Azione PACB
- Società Pacific Biosciences of California, Inc.